ORIFLAME CONFIRMS IMPLEMENTATION OF AGREED RECAPITALISATION TRANSACTION AND ADDITIONAL INCREMENTAL FACILITY

London, United Kingdom – December 18, 2025 – Capitalized terms used herein but not defined shall have the meanings ascribed to such terms in the consent solicitation statement dated November 19, 2025 (the “Consent Solicitation Statement”). As previously announced on December 16, 2025, Oriflame Investment Holding Plc, 47 Esplanade, St Helier, Jersey, JE1 0BD (the “Issuer”) received valid and unrevoked consents from holders (the “Holders”) representing at least 90% of the aggregate principal amount of each series of Notes, including consents representing 98.40% of the Existing Dollar Notes and 96.21% of the Existing Euro Notes, thereby achieving the required consent threshold (the “Required Consents”) to approve certain amendments and the related issuance of €285.5 million 8.000%/12.500% PIK Senior Secured Second Lien Notes due 2032 (the “Notes”) pursuant to an amended and restated indenture to be entered into between, among others, the Issuer, the guarantors party thereto, GLAS Trustees Limited as trustee (the “Trustee”) and GLAS Trust Corporation Limited as security agent (the “Security Agent”), therefore the consent solicitation process (the “Solicitation”) has successfully closed. 

Following the closing of the Solicitation, the restructuring implementation deed between, among others, Oriflame Holding Limited, the Issuer, Oriflame Partners Limited, Oriflame Partners Holding Limited, the guarantors party thereto, the Trustee and the Security Agent, under which the signatories thereto agree to implement the Restructuring was executed on December 17, 2025.  

In addition, the Issuer has announced today an agreement with certain Bondholder New Money Providers and Shareholders to provide an additional approximately €21.5 million incremental facility under the Bondholder New Money Loan. This additional facility is to be funded on the Restructuring Effective Date and is being made available to ensure the Group has access to robust liquidity upon completion of the Restructuring. 

This announcement is for information purposes only and does not constitute an offer to purchase the Notes or a solicitation of an offer to sell the Notes and shall not be deemed to be an offer to purchase or a solicitation of an offer to sell any securities of the Issuer, or its respective subsidiaries or affiliates. The Solicitation is only being made pursuant to the terms of the Consent Solicitation Statement. No recommendation is being made as to whether Holders should consent to the proposed amendments. The Solicitation is not being made in any jurisdiction in which, or to or from any person to or from whom, it is unlawful to make such solicitation. 

Information Regarding Forward-Looking Statements 

This press release may contain statements about future events, projections, forecasts and expectations that are forward-looking statements. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Any statement in this press release that is not a statement of historical fact is a forward-looking statement that involves known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. In addition, past performance of Oriflame and its affiliates cannot be relied on as a guide to future performance. Oriflame and its affiliates make no representation or warranty (whether express or implied) and shall have no responsibility or liability on the accuracy and completeness of any of the forward-looking statements, and, except as may be required by applicable law, assume no obligations to supplement, amend, update or revise any such statements or any opinion expressed to reflect actual results, changes in assumptions or in Oriflame’s or its affiliates’ expectations, or changes in factors affecting these statements. Accordingly, any reliance you place on such forward-looking statements will be at your sole risk. Oriflame undertakes no obligation and does not intend to release publicly the result of any revisions to these forward-looking statements which may be made to reflect events or circumstances after the date hereof, including changes in the business or strategy or planned capital expenditures, or to reflect the occurrence of unanticipated events. New risks emerge from time to time, and it is not possible for the Issuer to predict all such risks, nor can the Issuer assess the impact of all such risks on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. 

About Oriflame 

As a globally renowned beauty and wellbeing company, Oriflame has empowered individuals since 1967 through its diverse portfolio of high-quality, innovative, and sustainable beauty and wellbeing products. It operates in over 60 markets. 

Committed to ethical business practices and environmental sustainability, Oriflame takes pride in its Swedish heritage and people-centric approach. It operates through a modern social selling model, enabling over 3 million Beauty Entrepreneurs and members worldwide to become beauty industry insiders through a ‘Plug and Play’ micro-entrepreneurship model. 

Oriflame’s product range spans skincare, cosmetics, fragrances, personal care, and nutritional supplements, all crafted with care to promote holistic wellbeing. Guided by the values of Togetherness, Spirit, and Passion, Oriflame continues to make a positive impact on communities worldwide and has been named a European Climate Leader by the Financial Times and Statista for the past five years. 

For more information, visit www.oriflame.com.